Changes in Testing and Diagnoses of Sexually Transmitted Infections and HIV During the COVID-19 Pandemic.

Abstract: We evaluated changes in rates of testing and diagnoses of sexually transmitted infections during the 2017-2020 period at Kaiser Permanente Southern California. During the COVID-19 pandemic period, we observed profound reductions in testing and fewer diagnoses of chlamydia, gonorrhea, and HIV compared with prepandemic periods, but syphilis diagnoses rates increased by 32%.
Competing Interests: Conflict of Interest and Sources of Funding: J.J.C. and Q.C. have no conflicts of interest to declare. R.C.H. has received funding from Gilead for unrelated research. J.D.-O. has funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development for unrelated research. K.J.B. has received funding from Gilead, Dynavax, GlaxoSmithKline, Moderna, and Pfizer for unrelated research.
(Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved.)